Postdoctoral Scientist
Columbia University Irving Medical Center
Melania is a Medical Biotechnologist (BS 2016, MS 2018) who completed her PhD in Computational Biology (2024) at the University of Naples, Italy. Her doctoral research focused on investigating vulnerabilities in EGFR-dependent breast cancer cells using single-cell lineage tracing and time-resolved computational analyses.
In early 2024, Melania joined Dr. Andrea Califano’s Lab in the Department of Systems Biology, where she is currently undertaking her postdoctoral training. Her research focuses on developing pharmacological strategies to combat drug resistance in rare pediatric sarcomas by identifying drugs targeting Tumor Checkpoint modules. Additionally, she is investigating tumor microenvironment (TME) remodeling in prostate cancer to uncover mechanisms that sustain immunosuppression following Master Regulators directed treatments.
